메뉴 건너뛰기




Volumn 25, Issue 1, 2013, Pages 24-28

Testosterone replacement therapy in the setting of prostate cancer treated with radiation

Author keywords

hypogonadism; prostate cancer; radiation therapy; testosterone replacement

Indexed keywords

ESTROGEN; HEMOGLOBIN; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

EID: 84872489211     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2012.29     Document Type: Article
Times cited : (78)

References (41)
  • 2
    • 80053940592 scopus 로고    scopus 로고
    • Census UBot 2010 Census UBot: Washington, DC
    • Census UBot. Age and sex composition: 2010Census UBot: Washington, DC, 2011.
    • (2011) Age and Sex Composition
  • 3
    • 84872491481 scopus 로고    scopus 로고
    • Summary from the 2nd Annual Andropause Consensus Meeting Chevy Chase, MD
    • Society TE. The Endocrine Society. Summary from the 2nd Annual Andropause Consensus Meeting Chevy Chase, MD 2001.
    • (2001) The Endocrine Society
    • Society, T.E.1
  • 4
    • 58149299559 scopus 로고    scopus 로고
    • The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction
    • Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 2009; 30: 10-22.
    • (2009) J Androl , vol.30 , pp. 10-22
    • Traish, A.M.1    Guay, A.2    Feeley, R.3    Saad, F.4
  • 5
    • 68149138117 scopus 로고    scopus 로고
    • The dark side of testosterone deficiency: III. Cardiovascular disease
    • Traish AM, Saad F, Feeley RJ, Guay A. The dark side of testosterone deficiency: III. Cardiovascular disease. J Androl 2009; 30: 477-494.
    • (2009) J Androl , vol.30 , pp. 477-494
    • Traish, A.M.1    Saad, F.2    Feeley, R.J.3    Guay, A.4
  • 6
    • 58149310816 scopus 로고    scopus 로고
    • The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance
    • Traish AM, Saad F, Guay A. The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. J Androl 2009; 30: 23-32.
    • (2009) J Androl , vol.30 , pp. 23-32
    • Traish, A.M.1    Saad, F.2    Guay, A.3
  • 7
    • 84928580276 scopus 로고
    • Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate
    • Huggins C, Hudges CV. Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate. Cancer Res 1941; 1: 293-297.
    • (1941) Cancer Res , vol.1 , pp. 293-297
    • Huggins, C.1    Hudges, C.V.2
  • 8
    • 13844262629 scopus 로고    scopus 로고
    • Comparative effects of DHEA vs tes-tosterone, dihydrotestosterone, and estradiol on proliferation and gene expres-sion in human LNCaP prostate cancer cells
    • Arnold JT, Le H, McFann KK, Blackman MR. Comparative effects of DHEA vs tes-tosterone, dihydrotestosterone, and estradiol on proliferation and gene expres-sion in human LNCaP prostate cancer cells. Am J Physiol Endocrinol Metab 2005; 288: E573-E584.
    • (2005) Am J Physiol Endocrinol Metab , vol.288
    • Arnold, J.T.1    Le McFann H, K.K.2    Blackman, M.R.3
  • 9
    • 12544256922 scopus 로고    scopus 로고
    • Testosterone replacement therapy after primary treatment for prostate cancer
    • Agarwal PK, Oefelein MG. Testosterone replacement therapy after primary treatment for prostate cancer. J Urol 2005; 173: 533-536.
    • (2005) J Urol , vol.173 , pp. 533-536
    • Agarwal, P.K.1    Oefelein, M.G.2
  • 10
    • 4143066958 scopus 로고    scopus 로고
    • Androgen replacement after curative radical prosta-tectomy for prostate cancer in hypogonadal men
    • Kaufman JM, Graydon RJ. Androgen replacement after curative radical prosta-tectomy for prostate cancer in hypogonadal men. J Urol 2004; 172: 920-922.
    • (2004) J Urol , vol.172 , pp. 920-922
    • Kaufman, J.M.1    Graydon, R.J.2
  • 12
    • 57649148622 scopus 로고    scopus 로고
    • Testosterone administration to men with tes-tosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: Preliminary observations
    • Morales A, Black AM, Emerson LE. Testosterone administration to men with tes-tosterone deficiency syndrome after external beam radiotherapy for localized prostate cancer: preliminary observations. BJU Int 2009; 103: 62-64.
    • (2009) BJU Int , vol.103 , pp. 62-64
    • Morales, A.1    Black, A.M.2    Emerson, L.E.3
  • 13
    • 33846688614 scopus 로고    scopus 로고
    • Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy
    • Sarosdy MF. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy. Cancer 2007; 109: 536-541.
    • (2007) Cancer , vol.109 , pp. 536-541
    • Sarosdy, M.F.1
  • 14
    • 79955394539 scopus 로고    scopus 로고
    • Effect of Testosterone Administration to Men with Prostate Cancer Is Unpredictable: A word of caution and suggestions for a registry
    • Morales A. Effect of testosterone administration to men with prostate cancer is unpredictable: a word of caution and suggestions for a registry. BJU Int 2011; 107: 1369-1373.
    • (2011) BJU Int , vol.107 , pp. 1369-1373
    • Morales, A.1
  • 17
    • 77951738484 scopus 로고    scopus 로고
    • Testosterone replacement in prostate cancer survivors with hypogonadal symptoms
    • Leibowitz RL, Dorff TB, Tucker S, Symanowski J, Vogelzang NJ. Testosterone replacement in prostate cancer survivors with hypogonadal symptoms. BJU Int 2010; 105: 1397-1401.
    • (2010) BJU Int , vol.105 , pp. 1397-1401
    • Leibowitz, R.L.1    Dorff, T.B.2    Tucker, S.3    Symanowski, J.4    Vogelzang, N.J.5
  • 19
    • 84872487104 scopus 로고    scopus 로고
    • NCCN. Prostate Cancer 2012
    • NCCN. Prostate Cancer 2012. http://www.nccn.org.
  • 21
    • 0036096199 scopus 로고    scopus 로고
    • What happens to testosterone after prostate radiation monotherapy and does it matter?
    • Pickles T, Graham P. What happens to testosterone after prostate radiation monotherapy and does it matter? J Urol 2002; 167: 2448-2452.
    • (2002) J Urol , vol.167 , pp. 2448-2452
    • Pickles, T.1    Graham, P.2
  • 22
    • 0030776408 scopus 로고    scopus 로고
    • Serum testosterone levels after external beam radiation for clinically localized prostate cancer
    • Zagars GK, Pollack A. Serum testosterone levels after external beam radiation for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1997; 39: 85-89.
    • (1997) Int J Radiat Oncol Biol Phys , vol.39 , pp. 85-89
    • Zagars, G.K.1    Pollack, A.2
  • 23
    • 0024345285 scopus 로고
    • Effects of radiation therapy and chemotherapy on testicular function
    • discussion 172-157
    • Kinsella TJ. Effects of radiation therapy and chemotherapy on testicular function. Prog Clin Biol Res 1989; 302: 157-171(discussion 172-157).
    • (1989) Prog Clin Biol Res , vol.302 , pp. 157-171
    • Kinsella, T.J.1
  • 24
    • 0022575074 scopus 로고
    • The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate
    • Grigsby PW, Perez CA. The effects of external beam radiotherapy on endocrine function in patients with carcinoma of the prostate. J Urol 1986; 135: 726-727.
    • (1986) J Urol , vol.135 , pp. 726-727
    • Grigsby, P.W.1    Perez, C.A.2
  • 26
    • 0020507128 scopus 로고
    • Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone, follicle-stimulating hormone, luteinizing hormone and prolactin
    • Tomic R, Bergman B, Damber JE, Littbrand B, Lofroth PO. Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone, follicle-stimulating hormone, luteinizing hormone and prolactin. J Urol 1983; 130: 287-289.
    • (1983) J Urol , vol.130 , pp. 287-289
    • Tomic, R.1    Bergman, B.2    Damber, J.E.3    Littbrand, B.4    Lofroth, P.O.5
  • 28
    • 0018975785 scopus 로고
    • Total and SHBG-bound testosterone and 5 alpha-dihydrotesto-sterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma
    • Lukkarinen O. Total and SHBG-bound testosterone and 5 alpha-dihydrotesto-sterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma. Br J Urol 1980; 52: 377-380.
    • (1980) Br J Urol , vol.52 , pp. 377-380
    • Lukkarinen, O.1
  • 29
    • 0019464367 scopus 로고
    • Suppressive effects of surgical stress on circulating androgens during and after prostatectomy
    • Ghanadian R, Puah CM, Williams G, Shah PJ, McWhinney N. Suppressive effects of surgical stress on circulating androgens during and after prostatectomy. Br J Urol 1981; 53: 147-149.
    • (1981) Br J Urol , vol.53 , pp. 147-149
    • Ghanadian, R.1    Puah, C.M.2    Williams, G.3    Shah, P.J.4    McWhinney, N.5
  • 30
    • 84856530228 scopus 로고    scopus 로고
    • A Multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(R)) insertion
    • McCullough AR, Khera M, Goldstein I, Hellstrom WJ, Morgentaler A, Levine LA. A Multi-institutional observational study of testosterone levels after testosterone pellet (Testopel(R)) insertion. J Sex Med 2012; 9: 594-601.
    • (2012) J Sex Med , vol.9 , pp. 594-601
    • McCullough, A.R.1    Khera, M.2    Goldstein, I.3    Hellstrom, W.J.4    Morgentaler, A.5    Levine, L.A.6
  • 31
    • 0034872990 scopus 로고    scopus 로고
    • Pretreat-ment nomogram for predicting freedom from recurrence after permanent pros-tate brachytherapy in prostate cancer
    • Kattan MW, Potters L, Blasko JC, Beyer DC, Fearn P, Cavanagh W et al. Pretreat-ment nomogram for predicting freedom from recurrence after permanent pros-tate brachytherapy in prostate cancer. Urology 2001; 58: 393-399.
    • (2001) Urology , vol.58 , pp. 393-399
    • Kattan, M.W.1    Potters, L.2    Blasko, J.C.3    Beyer, D.C.4    Fearn, P.5    Cavanagh, W.6
  • 32
    • 0033526343 scopus 로고    scopus 로고
    • Radiation therapy for clinically ocalized prostate cancer: A multi-institutional pooled analysis
    • Shipley WU, Thames HD, Sandler HM, Hanks GE, Zietman AL, Perez CA et al. Radiation therapy for clinically ocalized prostate cancer: a multi-institutional pooled analysis. JAMA 1999; 281: 1598-1604.
    • (1999) JAMA , vol.281 , pp. 1598-1604
    • Shipley, W.U.1    Thames, H.D.2    Sandler, H.M.3    Hanks, G.E.4    Zietman, A.L.5    Perez, C.A.6
  • 33
    • 0041564148 scopus 로고    scopus 로고
    • Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy
    • Pollack A, Hanlon AL, Movsas B, Hanks GE, Uzzo R, Horwitz EM. Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57: 19-23.
    • (2003) Int J Radiat Oncol Biol Phys , vol.57 , pp. 19-23
    • Pollack, A.1    Hanlon, A.L.2    Movsas, B.3    Hanks, G.E.4    Uzzo, R.5    Horwitz, E.M.6
  • 34
    • 0026322130 scopus 로고
    • The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer
    • Holzman M, Carlton Jr. CE, Scardino PT. The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer. J Urol 1991; 146: 1578-1582.
    • (1991) J Urol , vol.146 , pp. 1578-1582
    • Holzman, M.1    Carlton Jr., C.E.2    Scardino, P.T.3
  • 35
    • 57649176913 scopus 로고    scopus 로고
    • Shifting the paradigm of testosterone and prostate cancer: The saturation model and the limits of androgen-dependent growth
    • Morgentaler A, Traish AM. Shifting the paradigm of testosterone and prostate cancer: the saturation model and the limits of androgen-dependent growth. Eur Urol 2009; 55: 310-320.
    • (2009) Eur Urol , vol.55 , pp. 310-320
    • Morgentaler, A.1    Traish, A.M.2
  • 36
    • 13744261444 scopus 로고    scopus 로고
    • Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: A multi-institutional pooled analysis
    • Horwitz EM, Thames HD, Kuban DA, Levy LB, Kupelian PA, Martinez AA et al. Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis. J Urol 2005; 173: 797-802.
    • (2005) J Urol , vol.173 , pp. 797-802
    • Horwitz, E.M.1    Thames, H.D.2    Kuban, D.A.3    Levy, L.B.4    Kupelian, P.A.5    Martinez, A.A.6
  • 37
    • 83955165856 scopus 로고    scopus 로고
    • Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: A randomised, phase 3 trial
    • Warde P, Mason M, Ding K, Kirkbride P, Brundage M, Cowan R et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011; 378: 2104-2111.
    • (2011) Lancet , vol.378 , pp. 2104-2111
    • Warde, P.1    Mason, M.2    Ding, K.3    Kirkbride, P.4    Brundage, M.5    Cowan, R.6
  • 38
    • 77957779215 scopus 로고    scopus 로고
    • Testosterone suppresses hepcidin in men: A potential mechanism for testosterone-induced erythrocytosis
    • Bachman E, Feng R, Travison T, Li M, Olbina G, Ostland V et al. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab 2010; 95: 4743-4747.
    • (2010) J Clin Endocrinol Metab , vol.95 , pp. 4743-4747
    • Bachman, E.1    Feng, R.2    Travison, T.3    Li, M.4    Olbina, G.5    Ostland, V.6
  • 39
    • 0033304555 scopus 로고    scopus 로고
    • Pharmaco-kinetics efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men
    • Dobs AS, Meikle AW, Arver S, Sanders SW, Caramelli KE, Mazer NA. Pharmaco-kinetics efficacy, and safety of a permeation-enhanced testosterone transdermal system in comparison with bi-weekly injections of testosterone enanthate for the treatment of hypogonadal men. J Clin Endocrinol Metab 1999; 84: 3469-3478.
    • (1999) J Clin Endocrinol Metab , vol.84 , pp. 3469-3478
    • Dobs, A.S.1    Meikle, A.W.2    Arver, S.3    Sanders, S.W.4    Caramelli, K.E.5    Mazer, N.A.6
  • 40
    • 79953313802 scopus 로고    scopus 로고
    • A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treat-ment of male hypogonadism
    • Kaminetsky JC, Moclair B, Hemani M, Sand M. A phase IV prospective evaluation of the safety and efficacy of extended release testosterone pellets for the treat-ment of male hypogonadism. J Sex Med 2011; 8: 1186-1196.
    • (2011) J Sex Med , vol.8 , pp. 1186-1196
    • Kaminetsky, J.C.1    Moclair, B.2    Hemani, M.3    Sand, M.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.